{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Obese&page=13", "query": { "condition": "Obese", "page": 13 }, "page_size": 10 }, "pagination": { "page": 13, "page_size": 10, "total_count": 6014, "total_pages": 602, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Obese&page=14&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Obese&page=12&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-20T07:17:38.902Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00624858", "title": "A Study of Naltrexone SR/ Bupropion SR in Overweight or Obese Subjects With Major Depression", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Depression" ], "interventions": [ { "name": "naltrexone SR 32 mg/ bupropion SR 360 mg daily", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Orexigen Therapeutics, Inc", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 25, "start_date": "2008-01", "completion_date": "2009-07", "has_results": false, "last_update_posted_date": "2012-10-30", "last_synced_at": "2026-10-20T07:17:38.902Z", "location_count": 1, "location_summary": "Mason, Ohio", "locations": [ { "city": "Mason", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT00624858" }, { "nct_id": "NCT03801174", "title": "Using Partners to Enhance Long-Term Weight Loss", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Obesity" ], "interventions": [ { "name": "Partner-assisted intervention", "type": "BEHAVIORAL" }, { "name": "Patient-only intervention", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "University of Wisconsin, Madison", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "74 Years", "sex": "ALL", "summary": "18 Years to 74 Years" }, "enrollment_count": 346, "start_date": "2019-01-15", "completion_date": "2023-03-20", "has_results": true, "last_update_posted_date": "2024-06-06", "last_synced_at": "2026-10-20T07:17:38.902Z", "location_count": 1, "location_summary": "Madison, Wisconsin", "locations": [ { "city": "Madison", "state": "Wisconsin" } ], "official_url": "https://clinicaltrials.gov/study/NCT03801174" }, { "nct_id": "NCT03840928", "title": "PatientSpot Formerly Known as ArthritisPower", "overall_status": "UNKNOWN", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Rheumatoid Arthritis", "Ankylosing Spondylitis", "Fibromyalgia", "Gout", "Crohn Disease", "Juvenile Idiopathic Arthritis", "Lupus Erythematosus", "Myositis", "Osteoarthritis", "Osteoporosis", "Psoriasis", "Psoriatic Arthritis", "Scleroderma", "Dermatomyositis", "Inflammatory Bowel Diseases", "Polymyositis", "Axial Spondyloarthritis", "Diffuse Idiopathic Skeletal Hyperostosis", "Polymyalgia Rheumatica", "Giant Cell Arteritis", "Temporal Arteritis", "Wegener", "Relapsing Polychondritis", "Undifferentiated Connective Tissue Disease", "Spinal Cord Injuries", "Alzheimer Disease", "Amyotrophic Lateral Sclerosis", "Ataxia", "Bell Palsy", "Brain Tumor", "Cerebral Aneurysm", "Epilepsy", "Guillain-Barre Syndrome", "Headache", "Head Injury", "Hydrocephalus", "Lumbar Disc Disease", "Meningitis", "Multiple Sclerosis", "Muscular Dystrophy", "Neurocutaneous Syndromes", "Parkinson Disease", "Stroke", "Cluster Headache", "Tension-Type Headache", "Chronic Obstructive Pulmonary Disease", "Asthma", "Lung Cancer", "Cystic Fibrosis", "Sleep Apnea", "Eczema", "Alopecia", "Chronic Inflammation", "Unstable Angina", "Heart Attack", "Heart Failure", "Arrythmia", "Valve Heart Disease", "High Blood Pressure", "Congenital Heart Disease", "Peripheral Arterial Disease", "Diabetes", "Chronic Liver Disease", "Obesity" ], "interventions": [], "intervention_types": [], "sponsor": "Global Healthy Living Foundation", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "19 Years", "maximum_age": null, "sex": "ALL", "summary": "19 Years and older" }, "enrollment_count": 40000, "start_date": "2015-04-01", "completion_date": "2025-03-01", "has_results": false, "last_update_posted_date": "2023-12-13", "last_synced_at": "2026-10-20T07:17:38.902Z", "location_count": 1, "location_summary": "Upper Nyack, New York", "locations": [ { "city": "Upper Nyack", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT03840928" }, { "nct_id": "NCT03851458", "title": "Consumption of More Ideal Food Options (COMIDA: Consumo de Opciones Más Ideales De Alimentos)", "overall_status": "ENROLLING_BY_INVITATION", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Overweight", "Obesity" ], "interventions": [ { "name": "Initial in-person individual diet and exercise counseling (N vs. Y)", "type": "BEHAVIORAL" }, { "name": "Thrice weekly diet and exercise text messages (N vs. Y)", "type": "BEHAVIORAL" }, { "name": "Weekly telephone support (N vs. Y)", "type": "BEHAVIORAL" }, { "name": "Self-monitoring tools (N vs. Y) (for diet and weight)", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "Memorial Sloan Kettering Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 1785, "start_date": "2015-05-05", "completion_date": "2027-05", "has_results": false, "last_update_posted_date": "2026-07-06", "last_synced_at": "2026-10-20T07:17:38.902Z", "location_count": 1, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT03851458" }, { "nct_id": "NCT00634036", "title": "Pilot Study of Pioglitazone for the Treatment of Moderate to Severe Asthma in Obese Asthmatics", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "pioglitazone", "type": "DRUG" }, { "name": "placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Fernando Holguin", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "60 Years", "sex": "ALL", "summary": "18 Years to 60 Years" }, "enrollment_count": 23, "start_date": "2009-10", "completion_date": "2012-04", "has_results": true, "last_update_posted_date": "2017-07-19", "last_synced_at": "2026-10-20T07:17:38.902Z", "location_count": 2, "location_summary": "Pittsburgh, Pennsylvania • Colchester, Vermont", "locations": [ { "city": "Pittsburgh", "state": "Pennsylvania" }, { "city": "Colchester", "state": "Vermont" } ], "official_url": "https://clinicaltrials.gov/study/NCT00634036" }, { "nct_id": "NCT03111264", "title": "Building Blocks for Healthy Preschoolers", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Pediatric Obesity" ], "interventions": [ { "name": "CHAMP+", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "University of Maryland, Baltimore", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 1943, "start_date": "2016-06-17", "completion_date": "2020-03-13", "has_results": false, "last_update_posted_date": "2021-05-10", "last_synced_at": "2026-10-20T07:17:38.902Z", "location_count": 1, "location_summary": "Baltimore, Maryland", "locations": [ { "city": "Baltimore", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT03111264" }, { "nct_id": "NCT03116334", "title": "Genetic Influences Between Cognitive Function and BMI", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Obesity" ], "interventions": [], "intervention_types": [], "sponsor": "Baylor College of Medicine", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "7 Years", "maximum_age": "15 Years", "sex": "ALL", "summary": "7 Years to 15 Years" }, "enrollment_count": 869, "start_date": "2009-09", "completion_date": "2016-12", "has_results": false, "last_update_posted_date": "2017-04-18", "last_synced_at": "2026-10-20T07:17:38.902Z", "location_count": 1, "location_summary": "Houston, Texas", "locations": [ { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT03116334" }, { "nct_id": "NCT07477704", "title": "A Study to See How Safe and Effective Alirocumab is When Given Weekly to Adult Participants Who Have Hypercholesterolemia", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Hypercholesterolemia" ], "interventions": [ { "name": "Alirocumab", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Regeneron Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 438, "start_date": "2026-06-17", "completion_date": "2027-02-23", "has_results": false, "last_update_posted_date": "2026-10-15", "last_synced_at": "2026-10-20T07:17:38.902Z", "location_count": 34, "location_summary": "Anniston, Alabama • Cullman, Alabama • Anaheim, California + 30 more", "locations": [ { "city": "Anniston", "state": "Alabama" }, { "city": "Cullman", "state": "Alabama" }, { "city": "Anaheim", "state": "California" }, { "city": "Los Alamitos", "state": "California" }, { "city": "Walnut Creek", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT07477704" }, { "nct_id": "NCT04649047", "title": "Lifestyle Behavior Weight Loss Intervention", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Obesity", "Weight Loss" ], "interventions": [ { "name": "Goal-oriented episodic future thinking", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "Ohio State University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "45 Years", "sex": "FEMALE", "summary": "18 Years to 45 Years · Female only" }, "enrollment_count": 15, "start_date": "2021-02-01", "completion_date": "2023-07-01", "has_results": true, "last_update_posted_date": "2025-01-31", "last_synced_at": "2026-10-20T07:17:38.902Z", "location_count": 1, "location_summary": "Columbus, Ohio", "locations": [ { "city": "Columbus", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT04649047" }, { "nct_id": "NCT04439448", "title": "Adipose Tissue and Immune Activation in HIV", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Human Immunodeficiency Virus", "Obesity" ], "interventions": [ { "name": "dual-energy X-ray absorptiometry (DEXA) scan", "type": "RADIATION" }, { "name": "Carotid and branchial artery ultrasound", "type": "OTHER" }, { "name": "2-hour oral glucose tolerace test", "type": "DIAGNOSTIC_TEST" }, { "name": "Blood collection", "type": "DIAGNOSTIC_TEST" } ], "intervention_types": [ "RADIATION", "OTHER", "DIAGNOSTIC_TEST" ], "sponsor": "Vanderbilt University Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 100, "start_date": "2013-04-12", "completion_date": "2020-02-15", "has_results": false, "last_update_posted_date": "2020-06-19", "last_synced_at": "2026-10-20T07:17:38.902Z", "location_count": 1, "location_summary": "Nashville, Tennessee", "locations": [ { "city": "Nashville", "state": "Tennessee" } ], "official_url": "https://clinicaltrials.gov/study/NCT04439448" } ] }